Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
105.25
-3.42 (-3.15%)
At close: Jun 8, 2026, 4:00 PM EDT
105.00
-0.25 (-0.24%)
After-hours: Jun 8, 2026, 4:10 PM EDT
Palvella Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $270 | Buy | Maintains | $270 | +156.53% | Jun 4, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $240 | Buy | Reiterates | $240 | +128.03% | Jun 4, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $227 | Buy | Maintains | $227 | +115.68% | May 22, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 21, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $210 | Buy | Reiterates | $210 | +99.52% | May 21, 2026 |
| Chardan Capital | Chardan Capital | Buy Reiterates $240 | Buy | Reiterates | $240 | +128.03% | May 21, 2026 |
| Stephens | Stephens | Buy Initiates $220 | Buy | Initiates | $220 | +109.03% | May 12, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $267 | Buy | Maintains | $267 | +153.68% | May 8, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.